Literature DB >> 26189783

URB937, a peripherally restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibres in rats.

Naoki Aizawa1, Giorgio Gandaglia2,3, Petter Hedlund4, Tetsuya Fujimura5, Hiroshi Fukuhara5, Francesco Montorsi2, Yukio Homma5, Yasuhiko Igawa1.   

Abstract

OBJECTIVE: To determine if inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) can counteract the changes in urodynamic variables and bladder afferent activities induced by intravesical prostaglandin E2 (PGE2 ) instillation in rats.
MATERIALS AND METHODS: In female Sprague-Dawley rats we studied the effects of URB937, a peripherally restricted FAAH inhibitor, on single-unit afferent activity (SAA) during PGE2 -induced bladder overactivity (BO). SAA measurements were made in urethane-anaesthetised rats and Aδ- and C-fibres were identified by electrical stimulation of the pelvic nerve and by bladder distention. Cystometry (CMG) in conscious animals and during SAA measurements was performed during intravesical instillation of PGE2 (50 or 100 μm) after intravenous administration of URB937 (0.1 and 1 mg/kg) or vehicle. In separate experiments, the comparative expressions of FAAH and cannabinoid receptors, CB1 and CB2 , in microsurgically removed L6 dorsal root ganglion (DRG) were studied by immunofluorescence.
RESULTS: During CMG, 1 mg/kg URB937, but not vehicle or 0.1 mg/kg URB937, counteracted the PGE2 -induced changes in urodynamic variables. PGE2 increased the SAAs of C-fibres, but not Aδ-fibres. URB937 (1 mg/kg) depressed Aδ-fibre SAA and abolished the facilitated C-fibre SAA induced by PGE2 . The DRG nerve cells showed strong staining for FAAH, CB1 and CB2 , with a mean (sem) of 77 (2)% and 87 (3)% of FAAH-positive nerve cell bodies co-expressing CB1 or CB2 immunofluorescence, respectively.
CONCLUSION: The present results show that URB937, a peripherally restricted FAAH inhibitor, reduces BO and C-fibre hyperactivity in the rat bladder provoked by PGE2 , suggesting an important role of the peripheral endocannabinoid system in BO and hypersensitivity.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Afferent; Sprague-Dawley rats; endocannabinoids; prostaglandin E2; urinary bladder

Mesh:

Substances:

Year:  2015        PMID: 26189783     DOI: 10.1111/bju.13223

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Stimulation of the pelvic nerve increases bladder capacity in the prostaglandin E2 rat model of overactive bladder.

Authors:  Christopher L Langdale; James A Hokanson; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

Review 2.  The endocannabinoid system - a target for the treatment of LUTS?

Authors:  Petter Hedlund; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2016-07-05       Impact factor: 14.432

3.  Stimulation of the pelvic nerve increases bladder capacity in the PGE2 cat model of overactive bladder.

Authors:  Christopher L Langdale; James A Hokanson; Philip H Milliken; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-20

4.  Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.

Authors:  Ana Charrua; Rita Matos; Raquel Oliveira; Tim Marczylo; Istvan Nagy; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-15       Impact factor: 3.000

5.  Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1.

Authors:  Qudong Lu; Yang Yang; Hengshuai Zhang; Cheng Chen; Jiang Zhao; Zhenxing Yang; Yi Fan; Longkun Li; Huan Feng; Jingzhen Zhu; Shanhong Yi
Journal:  Drug Des Devel Ther       Date:  2021-11-15       Impact factor: 4.162

Review 6.  Endocannabinoids in Bladder Sensory Mechanisms in Health and Diseases.

Authors:  Stewart Christie; Simon Brookes; Vladimir Zagorodnyuk
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

Review 7.  Potential of Endocannabinoids to Control Bladder Pain.

Authors:  Dale E Bjorling; Zun-Yi Wang
Journal:  Front Syst Neurosci       Date:  2018-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.